Hanmi to roll out new combination NSAID drug

Published: 2013-10-24 06:56:00

Updated: 2013-10-24 06:56:00

Hanmi Pharmaceutical Co. said Wednesday that it will launch a combination drug Naxozol, which combines the two most commonly prescribed naproxen, a non-steroidal anti-inflammatory agent (NSAID) and esomeprazole strontium in one tablet, from next month.

Naproxen is often effective in combating ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK